DR JOHN AINSWORTH PE

12 Top Israeli Stocks

I HAVE BEEN LONG CHKP FOR YEARS. WHILE THE STOCK ITSELF HAS AN INTERESTING HISTORY, IT HAS BEEN ONE OF MY MOST PROFITABLE POSITIONS, ALONG WITH INTC, MENTIONED IN THIS ARTICLE, BUT NOT PART OF ITS COMMENTS.

THE GREAT PROFIT FROM CHKP COMES FROM ITS ABILITY TO OFFER ABOVE AVERAGE OPTIONS PREMIUM FROM THE SELLING OF COVERED CALLS. IF ONE IS ON TOP OF HIS PORTFOLIO POSITIONS, HE CAN ACHIEVE A 14 PERCENT GAIN FROM COVERED CALL OPTIONS PREMIUM. THIS METHOD, USING THE RULE OF 72, DOUBLES HIS POSITION VALUE IN 5 YEARS. THIS HAS BEEN MY EXPERIENCE OVER THE LAST 15 YEARS.

I AM CURRENTLY LOOKING AT OTHER POTENTIAL POSITIONS IN THE ISREAL STOCK MARKET WHICH ARE LISTED IN THE U.S. MARKETS.

FINALLY, THE FACT THAT BUFFETT BOUGHT ISCAR IS IRRELIVENT TO ME. BUFFETT'S (BRK.A OR BRK.B) HAS NO INTEREST TO THIS INVERTOR. HEY DR JOHN "WHY YOU SAY?" THE ANSWER IS VERY SIMPLE.......NO OPTIONS ON BIRKIE'S STOCK.

WHEN COMPARING MY PORTFOLIO TO BRK.A OR BRK.B OVER THE LONG TERM, MY POSITIONS OVERALL, HAVE OUT PERFORMED BUFFETT'S PORTFOLIO. PORTFOLIO PERFORMANCE IS MY ONLY CONCERN FROM INVESTMENT POSITIONS.

THANK YOU!
DR JOHN AINSWORTH PE